Floatz logo

aciclovir

Herpes Simplex 2

New York State Psychiatric InstituteSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Herpes Simplex 2 cohort.

Asset / SponsorPhaseRating
Valaciclovir
New York State Psychiatric Institute
Phase 2B

Same molecule, other indications

aciclovir is also rated in:

herpes simplex infectious diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
68 / 100
View asset →
herpes zosterDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →